17
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Morphologic, Immunophenotypic and in Vitro Growth Characteristics of Blood and Bone Marrow Associated with Stem Cell Mobilisation in Patients with Lymphoma

, , , &
Pages 351-361 | Received 28 Nov 1999, Published online: 01 Jul 2009

References

  • Peterson B A. The role of transplantation in non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2524–2526
  • Bierman J, Vose J M, Armitage J O. Autologous transplantation for Hodgkin's disease: coming of age. Blood 1994; 83: 1161–1164
  • Schots R, Van Riet I, Damiaens S. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplantation 1996; 17: 509–515
  • Prince M H, Imrie K, Sutherland R. Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. British Journal of Haemathology 1996; 93: 142–145
  • Haas R, Mohle R, Fruhauf S. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787–3794
  • Chatta G S, Price T H, Allen R C, Dale D C. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994; 84: 2923–2929
  • Koumakis G, Vassilomanolakis M, Hatzichristou H. Predictive factors affecting mobilisation and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplantation 1996; 18: 1065–1072
  • Bensinger W, Appelbaum F, Rowley S. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547–2555
  • Dreger P, Klöss M, Petersen B. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86: 3970–3978
  • Demirer T, Buckner C D, Gooley T. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplantation 1996; 17: 937–941
  • Kotasek D, Shepherd K M, Sage R E. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11–17
  • Coutinho L H, Gilleece M H, De Wynter E A. Clonal and long-term cultures using human bone marrow. Haemopoiesis. A practical approach, N G Testa, G Molineux. Oxford University Press, New York 1993; 75–105
  • Sutherland H J, Eaves C J, Lansdorp P M. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engeneered murine stromal cells. Blood 1991; 78: 666–672
  • Siena S, Bregni M, Brando B. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409
  • Stata Statistical Software [computer program]. Stata Corp. 5.0, College Station, TX 1997
  • Zon L I. Developmental biology of hematopoiesis. Blood 1995; 86: 2876–2891
  • Craig J IO, Anthony R S, Parker A C. Circulating progenitor cells in myelofibrosis: the effect of recombinant 2b inter-feron-alpha in vivo and in vitro. Br J Haematol 1991; 78: 155–160
  • Cournot G, Petrovic M, Trubert C-L. Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-Dihydroxyvitamin D3. J Bone Miner Res 1993; 8: 61–70
  • Höglund M, Smedmyr B, Simonsson B. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplantation 1996; 18: 19–27
  • Passos-Coelho J L, Braine H G, Davis J M. Predictive factors for peripheral-blood progenitor- cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13: 705–714
  • Fruehauf S, Haas R, Conradt C. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619–2626
  • Gilabert R, Ayats R. Human long-term bone marrow culture as a prognostic factor for hematopoietic reconstitution in autologous transplantation. Bone Marrow Transplantation 1994; 13: 635–640
  • Domenech J, Gihana E, Dayan A. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow culture. British Journal of Haematology 1994; 88: 488–496
  • DeLuca E, Sheridan W P, Watson D. Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992; 66: 893–899
  • Gordon M Y. The bone marrow stromal microenvironment. Hematological Oncology, A Burnett, J Armitage, A Newland, A Keating. Cambridge University Press, Cambridge 1994; 73–94
  • Brown R A, Adkins D, Goodnough L T. Factors That Influence the Collection and Engraftment of Allogeneic Peripheral-Blood Stem Cells in Patients With Hematologic Malignancies. J Clin Oncol 1997; 15: 3067–3074
  • Roberts A W, Begley C G, Grigg A P, Basser R L. Do steady-state peripheral blood progenitor cell (PBPC) counts predict the yield of PBPC mobilized by filgrastim alone. Blood 1995; 86: 2451
  • Weaver A, Ryder D, Crowther D. Increased Numbers of Long-Term Culture-Initiating Cells in the Apheresis Product of Patients Randomized to Receive Increasing Doses of Stem Cell Factor Administered in Combination With Chemotherapy and a Standard Dose of Granulocyte Colony-Stimulating Factor. Blood 1996; 88: 3323–3328
  • Carlo-Stella C, Dodero A, Regazzi E. Amifostine enhances chemotherapy-elicited peripheral blood progenitor cell mobilisation. Proc ASCO 1998; 17: 78a
  • Horning S J, Hoppe R T, Mason J. Stanford-Kaiser permanente G1 study for clinical stage I to HA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. J Clin Oncol 1997; 15: 1736–1744

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.